Trends and characteristics of cannabis-associated emergency department visits in the United States, 2006–2018. (1st March 2022)

• Record Type: Journal Article
• Authors: Roehler, Douglas R.; Hoots, Brooke E.; Holland, Kristin M.; Baldwin, Grant T.; Vivolo-Kantor, Alana M.
• Is Part Of: Drug and alcohol dependence. Volume 232(2022)
• Publication Date: 2022-03-01
• Subjects: Cannabis -- Surveillance -- Emergency medicine; Drug abuse -- Periodicals; Alcoholism -- Periodicals; 616.86
• DOI: 10.1016/j.drugalcdep.2022.109288
• Languages: English
• ISSNs: 0376-8716

Abstract

Abstract: Background: Cannabis policies are rapidly changing in the United States, yet little is known about how this has affected cannabis-associated emergency department (ED) visits. Methods: We studied trends in cannabis-associated ED visits and identified differences by visit characteristics. Cannabis-associated ED visits from 2006 to 2018 were identified from the Agency for Healthcare Research and Quality's Healthcare Cost and Utilization Project's (HCUP) Nationwide Emergency Department Sample (NEDS). JoinPoint analysis was used to identify trends from 2006 to 2014, prior to medical coding changes in 2015, and Z-tests were used to compare annual rate changes from 2016 to 2018. Changes in rates from 2017 to 2018 were examined by visit characteristics. Results: From 2006–2014, the rate of cannabis-associated ED visits increased, on average, 12.1% annually (p < 0.05), from 12.3 to 34.7 visits per 100, 000 population. The rate increased 17.3% from 2016 to 2017 (p < 0.05) and 11.1% from 2017 to 2018 (p < 0.05). From 2017–2018, rates of visits increased for both males (8.7%; p < 0.05) and females (15.9%; p < 0.05). Patients 0–14 years and 25 years and older had significant rate increases from 2017 to 2018 as did the Midwest region (36.8%; p < 0.05), the Northeast (9.2%; p < 0.05), and the South (4.5%; p < 0.05). Conclusions: Cannabis-associated ED visits are on the rise and subgroups are at increased risk. Some potential explanations for increases in cannabis-associated ED visits include increased availability of cannabis products, increased use, and diversity of products available in marketplaces. Strategies are needed to prevent youth initiation, limit potentially harmful use among adults, and ensure safe storage where cannabis use is legal. Highlights: From 2006–2014, rate of cannabis-associated ED visits increased 12.1% annually. The rate increased 17.3% from 2016 to 2017 and 11.1% from 2017 to 2018. From 2017–2018, rates of visits increased for males (8.7%) and females (15.9%). Patients 0–14 years and 25 + had significant rate increases from 2017 to 2018. As more states legalize, tailored interventions are needed to prevent acute visits.